Survivin as a target for new anticancer interventions (Q28257235)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15963255%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

review article

1 reference

title

Survivin as a target for new anticancer interventions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15963255%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

author name string

Nadia Zaffaroni

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15963255%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Marzia Pennati

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15963255%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Maria Grazia Daidone

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15963255%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

language of work or name

English

0 references

publication date

1 April 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15963255%20AND%20SRC:MED&resulttype=core&format=json

Journal of Cellular and Molecular Medicine

13 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15963255%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15963255%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

page(s)

360-372

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15963255%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15963255%20AND%20SRC:MED&resulttype=core&format=json

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

13 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1582-4934.2005.TB00361.X

Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1582-4934.2005.TB00361.X

Survivin splice variants regulate the balance between proliferation and cell death

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1582-4934.2005.TB00361.X

Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1582-4934.2005.TB00361.X

Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1582-4934.2005.TB00361.X

Direct interaction between survivin and Smac/DIABLO is essential for the anti-apoptotic activity of survivin during taxol-induced apoptosis

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1582-4934.2005.TB00361.X

Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1582-4934.2005.TB00361.X

Control of apoptosis and mitotic spindle checkpoint by survivin

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1582-4934.2005.TB00361.X

A p34(cdc2) survival checkpoint in cancer

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1582-4934.2005.TB00361.X

Validating survivin as a cancer therapeutic target

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1582-4934.2005.TB00361.X

Apoptosis-regulating proteins as targets for drug discovery

21 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2005.TB00361.X

Does resistance to apoptosis affect clinical response to antitumor drugs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2005.TB00361.X

Apoptosis is critical for drug response in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2005.TB00361.X

Transducing signals of life and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2005.TB00361.X

The Bcl-2 protein family: arbiters of cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2005.TB00361.X

Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2005.TB00361.X

Identification of a novel splice variant of the human anti-apoptopsis gene survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2005.TB00361.X

Pleiotropic cell-division defects and apoptosis induced by interference with survivin function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2005.TB00361.X

Down-regulation of survivin by antisense oligonucleotides increases apoptosis, inhibits cytokinesis and anchorage-independent growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2005.TB00361.X

Survivin is required for stable checkpoint activation in taxol-treated HeLa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2005.TB00361.X

Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2005.TB00361.X

Regulation of survivin function by Hsp90

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2005.TB00361.X

Survivin, versatile modulation of cell division and apoptosis in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2005.TB00361.X

Control of apoptosis during angiogenesis by survivin expression in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2005.TB00361.X

Analysis of human transcriptomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2005.TB00361.X

Nuclear survivin expression in mantle cell lymphoma is associated with cell proliferation and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2005.TB00361.X

Expression and prognostic significance of survivin in de novo acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2005.TB00361.X

Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2005.TB00361.X

Induction of survivin expression by taxol (paclitaxel) is an early event, which is independent of taxol-mediated G2/M arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2005.TB00361.X

Survivin as a radioresistance factor in pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2005.TB00361.X

Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2005.TB00361.X

Survivin inhibition induces human neural tumor cell death through caspase-independent and -dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2005.TB00361.X

Survivin as a therapeutic target for radiation sensitization in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2005.TB00361.X

Ribozyme-mediated down-regulation of survivin expression sensitizes human melanoma cells to topotecan in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2005.TB00361.X

Radiosensitization of human melanoma cells by ribozyme-mediated inhibition of survivin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2005.TB00361.X

Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2005.TB00361.X

Ribozyme-mediated cleavage of the human survivin mRNA and inhibition of antiapoptotic function of survivin in MCF-7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2005.TB00361.X

Short interfering RNAs as a tool for cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2005.TB00361.X

Knockdown of survivin expression by small interfering RNA reduces the clonogenic survival of human sarcoma cell lines independently of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2005.TB00361.X

Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2005.TB00361.X

mRNA localization signals can enhance the intracellular effectiveness of hammerhead ribozymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2005.TB00361.X

Approaches for the sequence-specific knockdown of mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2005.TB00361.X

Gene therapy for colon cancer by adeno-associated viral vector-mediated transfer of survivin Cys84Ala mutant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2005.TB00361.X

Inhibition of melanoma tumor growth in vivo by survivin targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2005.TB00361.X

Cancer gene therapy using a survivin mutant adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2005.TB00361.X

From bench to clinic with apoptosis-based therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2005.TB00361.X

Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2005.TB00361.X

The cancer antiapoptosis mouse survivin gene: characterization of locus and transcriptional requirements of basal and cell cycle-dependent expression

21 January 2018

1 reference

12 December 2020

Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties

1 reference

12 December 2020

A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy

1 reference

12 December 2020

Prognostic significance of survivin expression in diffuse large B-cell lymphomas.

1 reference

12 December 2020

Catalytic nucleic acids: from lab to applications

1 reference

12 December 2020

DNA demethylase is expressed in ovarian cancers and the expression correlates with demethylation of CpG sites in the promoter region of c-erbB-2 and survivin genes

1 reference

12 December 2020

The Survivin saga goes in vivo

1 reference

12 December 2020

Effects of survivin antagonists on growth of established tumors and B7-1 immunogene therapy

1 reference

12 December 2020

Human inhibitor of apoptosis protein (IAP) survivin participates in regulation of chromosome segregation and mitotic exit

1 reference

12 December 2020

Ribozyme-mediated attenuation of survivin expression sensitizes human melanoma cells to cisplatin-induced apoptosis

1 reference

12 December 2020

Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function

1 reference

12 December 2020

Regulation of microtubule stability and mitotic progression by survivin.

1 reference

12 December 2020

Induction of apoptosis in mesothelioma cells by antisurvivin oligonucleotides.

1 reference

12 December 2020

Suppression of survivin phosphorylation on Thr34 by flavopiridol enhances tumor cell apoptosis.

1 reference

12 December 2020

Use of siRNAs and Antisense Oligonucleotides Against Survivin RNA to Inhibit Steps Leading to Tumor Angiogenesis

1 reference

12 December 2020

Radiosensitization, after a combined treatment of survivin siRNA and irradiation, is correlated with the activation of caspases 3 and 7 in a wt-p53 sarcoma cell line, but not in a mt-p53 sarcoma cell line

1 reference

12 December 2020

Survivin mediates resistance to antiandrogen therapy in prostate cancer

1 reference

12 December 2020

Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization

1 reference

12 December 2020

1 reference

12 December 2020

The inhibitors of apoptosis (IAPs) and their emerging role in cancer

1 reference

12 December 2020

IAP family proteins--suppressors of apoptosis

1 reference

12 December 2020

10.1111/J.1582-4934.2005.TB00361.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15963255%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15963255%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference